Meticuly shines at ICOMS 2025: showcasing orthognathic solutions and global collaboration

Meticuly recently made a significant impact at the 26th International Conference on Oral and Maxillofacial Surgery (ICOMS 2025) in Singapore. This premier global event provided an invaluable platform to showcase our advanced, personalised implant solutions and connect with leading surgeons and industry partners from around the world.

Our presence at ICOMS 2025 was led by our CTO, Assoc. Prof. Dr. Chedtha Puncreobutr, and CFO, Douglas Abrams. Their leadership underscored Meticuly's commitment to both technological innovation and strategic market development in the field of oral and maxillofacial surgery.

At our booth, we generated considerable interest by demonstrating Meticuly's comprehensive range of orthognathic solutions. Surgeons were particularly keen to explore:

• Our advanced orthognathic solutions for complex jaw corrections, designed for unparalleled precision and predictability.

• The innovative approach to minimally invasive orthognathic solutions, which aims to enhance patient recovery and reduce surgical complexity.

• Our specialised solutions for orbital floor reconstruction, addressing intricate facial trauma and defects.

• Personalised implants for mandibular reconstruction, offering robust and aesthetically pleasing outcomes for jaw defects.

• Custom-designed solutions for maxillary reconstruction, tailored to restore the upper jaw with high accuracy.

The engagement at ICOMS 2025 was truly inspiring. We extend our sincere gratitude to all the surgeons from around the world who stopped by our booth. It was a privilege to connect with both new acquaintances and rekindle old connections, sharing insights into the latest advancements in personalized surgical care. Your interest and feedback drive our continuous innovation in Orthognathic Solutions and other CMF applications.

Meticuly remains dedicated to empowering oral and maxillofacial surgeons with cutting-edge, personalized implant technology that leads to superior patient outcomes. We look forward to building on the successful connections made at ICOMS 2025 as we continue to expand our global reach.